Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10859283rdf:typepubmed:Citationlld:pubmed
pubmed-article:10859283lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:10859283lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:10859283lifeskim:mentionsumls-concept:C0562508lld:lifeskim
pubmed-article:10859283lifeskim:mentionsumls-concept:C0155626lld:lifeskim
pubmed-article:10859283lifeskim:mentionsumls-concept:C0256103lld:lifeskim
pubmed-article:10859283lifeskim:mentionsumls-concept:C0288672lld:lifeskim
pubmed-article:10859283lifeskim:mentionsumls-concept:C0679199lld:lifeskim
pubmed-article:10859283lifeskim:mentionsumls-concept:C0678536lld:lifeskim
pubmed-article:10859283lifeskim:mentionsumls-concept:C0175566lld:lifeskim
pubmed-article:10859283lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:10859283lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:10859283pubmed:issue24lld:pubmed
pubmed-article:10859283pubmed:dateCreated2000-7-13lld:pubmed
pubmed-article:10859283pubmed:abstractTextLow-dose alteplase with standard-dose abciximab enhances reperfusion 90 minutes after acute myocardial infarction (MI). We combined standard-dose abciximab with low-dose reteplase for acute MI in 2 phases. Two heparin doses were also explored.lld:pubmed
pubmed-article:10859283pubmed:languageenglld:pubmed
pubmed-article:10859283pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10859283pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10859283pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10859283pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10859283pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10859283pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10859283pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10859283pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10859283pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10859283pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10859283pubmed:statusMEDLINElld:pubmed
pubmed-article:10859283pubmed:monthJunlld:pubmed
pubmed-article:10859283pubmed:issn1524-4539lld:pubmed
pubmed-article:10859283pubmed:issnTypeElectroniclld:pubmed
pubmed-article:10859283pubmed:day20lld:pubmed
pubmed-article:10859283pubmed:volume101lld:pubmed
pubmed-article:10859283pubmed:ownerNLMlld:pubmed
pubmed-article:10859283pubmed:pagination2788-94lld:pubmed
pubmed-article:10859283pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:meshHeadingpubmed-meshheading:10859283...lld:pubmed
pubmed-article:10859283pubmed:year2000lld:pubmed
pubmed-article:10859283pubmed:articleTitleTrial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group.lld:pubmed
pubmed-article:10859283pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10859283pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10859283pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10859283pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10859283pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:10859283pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10859283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10859283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10859283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10859283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10859283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10859283lld:pubmed